Correlation Between Dyadic International and Calithera Biosciences
Can any of the company-specific risk be diversified away by investing in both Dyadic International and Calithera Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dyadic International and Calithera Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dyadic International and Calithera Biosciences, you can compare the effects of market volatilities on Dyadic International and Calithera Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dyadic International with a short position of Calithera Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dyadic International and Calithera Biosciences.
Diversification Opportunities for Dyadic International and Calithera Biosciences
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Dyadic and Calithera is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Dyadic International and Calithera Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Calithera Biosciences and Dyadic International is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dyadic International are associated (or correlated) with Calithera Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Calithera Biosciences has no effect on the direction of Dyadic International i.e., Dyadic International and Calithera Biosciences go up and down completely randomly.
Pair Corralation between Dyadic International and Calithera Biosciences
Given the investment horizon of 90 days Dyadic International is expected to generate 0.26 times more return on investment than Calithera Biosciences. However, Dyadic International is 3.83 times less risky than Calithera Biosciences. It trades about 0.0 of its potential returns per unit of risk. Calithera Biosciences is currently generating about -0.19 per unit of risk. If you would invest 218.00 in Dyadic International on August 31, 2024 and sell it today you would lose (47.00) from holding Dyadic International or give up 21.56% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 8.29% |
Values | Daily Returns |
Dyadic International vs. Calithera Biosciences
Performance |
Timeline |
Dyadic International |
Calithera Biosciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Dyadic International and Calithera Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Dyadic International and Calithera Biosciences
The main advantage of trading using opposite Dyadic International and Calithera Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dyadic International position performs unexpectedly, Calithera Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Calithera Biosciences will offset losses from the drop in Calithera Biosciences' long position.Dyadic International vs. Cue Biopharma | Dyadic International vs. Eliem Therapeutics | Dyadic International vs. Inhibrx | Dyadic International vs. Molecular Partners AG |
Calithera Biosciences vs. Abeona Therapeutics | Calithera Biosciences vs. Affimed NV | Calithera Biosciences vs. Checkpoint Therapeutics | Calithera Biosciences vs. Adaptimmune Therapeutics Plc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
CEOs Directory Screen CEOs from public companies around the world | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Economic Indicators Top statistical indicators that provide insights into how an economy is performing |